Amarin Files Definitive Proxy Materials and Mails
Letter to Shareholders
Urges Shareholders to Vote “AGAINST” Sarissa’s
Proposals on the WHITE Proxy Card
Highlights Significant Changes Implemented Over
Last 18 Months – New Strategy, New Leadership Team and
Significantly Refreshed Board; Transformation Underway with Strong
Early Progress Advancing Geographic Expansion and Operational and
Financial Excellence
Underscores Sarissa’s Misguided Proxy Contest –
Sarissa Has No Plan or New Ideas and Slate is
Underqualified
Company Launches www.voteamarin.com,
Featuring Videos with Chairman, Per Wold-Olsen, and CEO, Karim
Mikhail and Providing Additional Information for
Shareholders
DUBLIN, Ireland and BRIDGEWATER. N.J. Jan. 31, 2023 (GLOBE
NEWSWIRE) – Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the
“Company”) today announced that it has filed definitive proxy
materials with the Securities and Exchange Commission (“SEC”) in
connection with its upcoming General Meeting of Shareholders
scheduled to be held on February 28, 2023. Shareholders of
record as of January 23, 2023, will be entitled to vote at the
meeting.
In conjunction with the definitive proxy filing, Amarin has mailed
a letter to the Company’s shareholders and launched a new campaign
website, www.voteamarin.com, featuring videos with the
Company’s Chairman of the Board, Per Wold-Olsen, and Chief
Executive Officer, Karim Mikhail. Amarin’s definitive proxy
materials and other materials regarding the Board of Directors’
recommendation for the General Meeting can be found at
www.voteamarin.com.
The full text of the letter being mailed to shareholders
follows:
Dear Shareholder,
Your refreshed Board of Directors has one clear priority:
enhancing the value of your investment in Amarin in the
short- and long-term. The last 18 months have been a story
of transformation. When Karim Mikhail was appointed as CEO in
August 2021, Amarin was at the height of its challenges – from
generic competition to operational missteps.
Change was needed; we acted with urgency to address Amarin’s
challenges in a fast-moving market. We have a new leadership team
with European commercial launch expertise and we instilled greater
financial discipline across the organization. Coupled with our
refreshed Board to match the current needs of the Company, we are
on our way to becoming a global, diversified cardiometabolic
player, which we believe will drive significant long-term
shareholder value. This is the NEW AMARIN.
Sarissa Capital Management – an activist hedge fund – has called a
General Meeting in an attempt to remove our newly appointed Board
Chair and nearly double the size of the Amarin Board with seven of
its own hand-picked candidates, three of whom are employees of
Sarissa itself. We are asking you to support Amarin’s strategy to
maximize shareholder value and vote “AGAINST” all of
Sarissa’s resolutions on the WHITE proxy card for
three reasons: